UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models

British journal of pharmacology, 1994-08, Vol.112 (4), p.1043-1048

1994

Volltextzugriff (PDF)

Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?

Naunyn-Schmiedeberg's archives of pharmacology, 1996-04, Vol.353 (5), p.482-488

1996

Volltextzugriff (PDF)

Hilbert: Gedenkband

1, 1971

Volltextzugriff (PDF)

Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency

Pharmazie, 2000-02, Vol.55 (2), p.83-86

2000

Volltextzugriff (PDF)

Novel Partial Agonists for the Histamine H3 Receptor with High in Vitro and in Vivo Activity

Journal of medicinal chemistry, 1999-10, Vol.42 (20), p.4269-4274

1999

Volltextzugriff (PDF)

(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H 3 receptors

Bioorganic & medicinal chemistry, 2000-05, Vol.8 (5), p.1139-1149

2000

Volltextzugriff (PDF)

Development of Chiral N-Alkylcarbamates as New Leads for Potent and Selective H3-Receptor Antagonists: Synthesis, Capillary Electrophoresis, and in Vitro and Oral in Vivo Activity

Journal of medicinal chemistry, 1999-02, Vol.42 (4), p.593-600

1999

Volltextzugriff (PDF)

Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity

Journal of medicinal chemistry, 1999-10, Vol.42 (20), p.4269-4274

1999

Volltextzugriff (PDF)

Development of Chiral N -Alkylcarbamates as New Leads for Potent and Selective H 3 -Receptor Antagonists: Synthesis, Capillary Electrophoresis, and in Vitro and Oral in Vivo Activity

Journal of medicinal chemistry, 1999-02, Vol.42 (4), p.593-600

1999

Volltextzugriff (PDF)

(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors

Bioorganic & medicinal chemistry, 2000-05, Vol.8 (5), p.1139-1149

2000

Volltextzugriff (PDF)

Novel histamine H 3 receptor antagonists: affinities in an H 3 receptor binding assay and potencies in two functional H 3 receptor models

British journal of pharmacology, 1994-08, Vol.112 (4), p.1043-1048

1994

Volltextzugriff (PDF)

Novel histamine H sub(3) receptor antagonists: Affinities in an H sub(3) receptor binding assay and potencies in two functional H sub(3) receptor models

British journal of pharmacology, 1994-01, Vol.112 (4), p.1043-1048

1994

Volltextzugriff (PDF)

P86 novel histamine H3-receptor antagonists: Affinities in an H3-receptor binding assay and potencies in two functional H3-receptor models

European journal of pharmaceutical sciences, 1994-09, Vol.2 (1-2), p.140

1994

Volltextzugriff (PDF)

P86 novel histamine H 3-receptor antagonists: Affinities in an H 3-receptor binding assay and potencies in two functional H 3-receptor models

European journal of pharmaceutical sciences, 1994, Vol.2 (1), p.140-140

1994

Volltextzugriff (PDF)

Novel Histamine H 3 ‐Receptor Antagonists with Benzyl Ether Structure or Related Moieties: Synthesis and Structure‐Activity Relationships

Archiv der Pharmazie (Weinheim), 1996-08, Vol.329 (8-9), p.379-385

1996

Volltextzugriff (PDF)

N-alkyl carbamates as potent and selective histamine H3- receptor antagonists

European journal of pharmaceutical sciences, 1996-09, Vol.4, p.S79-S79

1996

Volltextzugriff (PDF)

Potencies of antagonists chemically related to iodoproxyfan at histamine H sub(3) receptors in mouse brain cortex and guinea-pig ileum: Evidence for H sub(3) receptor heterogeneity?

Naunyn-Schmiedeberg's archives of pharmacology, 1996-04, Vol.353 (5), p.482-488

1996

Volltextzugriff (PDF)

Novel Histamine H3-Receptor Antagonists with Benzyl Ether Structure or Related Moieties: Synthesis and Structure-Activity Relationships

Archiv der Pharmazie (Weinheim), 1996-08, Vol.329 (8-9), p.379-385

1996

Volltextzugriff (PDF)

ChemInform Abstract: Substituted N‐Phenylcarbamates as Histamine H 3 Receptor Antagonists with Improved in vivo Potency

ChemInform, 2000-06, Vol.31 (24)

2000

Volltextzugriff (PDF)

ChemInform Abstract: Substituted N-Phenylcarbamates as Histamine H3 Receptor Antagonists with Improved in vivo Potency

ChemInform, 2000-06, Vol.31 (24), p.no-no

2000

Volltextzugriff (PDF)

ChemInform Abstract: Novel Histamine H3-Receptor Antagonists with Benzyl Ether Structure or Related Moieties: Synthesis and Structure-Activity Relationships

ChemInform, 1997-01, Vol.28 (4), p.no-no

1997

Volltextzugriff (PDF)

Patient-centric drug product development: Acceptability across patient populations – Science and evidence

European journal of pharmaceutics and biopharmaceutics, 2023-07, Vol.188, p.1-5

2023

Volltextzugriff (PDF)

A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population

Therapeutic innovation & regulatory science, 2022-11, Vol.56 (6), p.903-909

2022

Volltextzugriff (PDF)

Validating a composite endpoint for acceptability evaluation of oral drug formulations in the pediatric population: a randomized, open-label, single dose, cross-over study

Frontiers in pharmacology, 2024-08, Vol.15, p.1436554

2024

Volltextzugriff (PDF)

Questionnaire Study to Investigate the Preferences of Children, Parents, and Healthcare Professionals for Different Formulations of Oral Medicinal Products

Pharmaceutics, 2024-04, Vol.16 (4), p.515

2024

Volltextzugriff (PDF)

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(204)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models

Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?

Hilbert: Gedenkband

Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency

Novel Partial Agonists for the Histamine H3 Receptor with High in Vitro and in Vivo Activity

(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H 3 receptors

Development of Chiral N-Alkylcarbamates as New Leads for Potent and Selective H3-Receptor Antagonists: Synthesis, Capillary Electrophoresis, and in Vitro and Oral in Vivo Activity

Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity

Development of Chiral N -Alkylcarbamates as New Leads for Potent and Selective H 3 -Receptor Antagonists: Synthesis, Capillary Electrophoresis, and in Vitro and Oral in Vivo Activity

(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors

Novel histamine H 3 receptor antagonists: affinities in an H 3 receptor binding assay and potencies in two functional H 3 receptor models

Novel histamine H sub(3) receptor antagonists: Affinities in an H sub(3) receptor binding assay and potencies in two functional H sub(3) receptor models

P86 novel histamine H3-receptor antagonists: Affinities in an H3-receptor binding assay and potencies in two functional H3-receptor models

P86 novel histamine H 3-receptor antagonists: Affinities in an H 3-receptor binding assay and potencies in two functional H 3-receptor models

Novel Histamine H 3 ‐Receptor Antagonists with Benzyl Ether Structure or Related Moieties: Synthesis and Structure‐Activity Relationships

N-alkyl carbamates as potent and selective histamine H3- receptor antagonists

Potencies of antagonists chemically related to iodoproxyfan at histamine H sub(3) receptors in mouse brain cortex and guinea-pig ileum: Evidence for H sub(3) receptor heterogeneity?

Novel Histamine H3-Receptor Antagonists with Benzyl Ether Structure or Related Moieties: Synthesis and Structure-Activity Relationships

ChemInform Abstract: Substituted N‐Phenylcarbamates as Histamine H 3 Receptor Antagonists with Improved in vivo Potency

ChemInform Abstract: Substituted N-Phenylcarbamates as Histamine H3 Receptor Antagonists with Improved in vivo Potency

ChemInform Abstract: Novel Histamine H3-Receptor Antagonists with Benzyl Ether Structure or Related Moieties: Synthesis and Structure-Activity Relationships

Patient-centric drug product development: Acceptability across patient populations – Science and evidence

A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population

Validating a composite endpoint for acceptability evaluation of oral drug formulations in the pediatric population: a randomized, open-label, single dose, cross-over study

Questionnaire Study to Investigate the Preferences of Children, Parents, and Healthcare Professionals for Different Formulations of Oral Medicinal Products

Suchergebnisse filtern